Clinical Trial Update: Pain and Visual Outcome in Intravitreal Bevacizumab Injection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating pain and visual outcomes after intravitreal bevacizumab injections for diabetic macular edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED